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Abstract 25 
Multiprotein chromatin remodelling complexes show remarkable conservation of 26 
function amongst metazoans, even though components present in invertebrates are often 27 
found as multiple paralogous proteins in vertebrate complexes. In some cases these 28 
paralogues specify distinct biochemical and/or functional activities in vertebrate cells. Here 29 
we set out to define the biochemical and functional diversity encoded by one such group of 30 
proteins within the mammalian Nucleosome Remodelling and Deacetylation (NuRD) 31 
complex: Mta1, Mta2 and Mta3. We find that, in contrast to what has been described in 32 
somatic cells, MTA proteins are not mutually exclusive within ES cell NuRD and, despite 33 
subtle differences in chromatin binding and biochemical interactions, serve largely 34 
redundant functions. ES cells lacking all three MTA proteins represent a complete NuRD null 35 
and are viable, allowing us to identify a previously unreported function for NuRD in reducing 36 
transcriptional noise, which is essential for maintaining a proper differentiation trajectory 37 
during early stages of lineage commitment. 38 
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Introduction 42 
Mammalian cells contain a number of proteins capable of using ATP hydrolysis to shift 43 
nucleosomes relative to the DNA sequence, thereby facilitating chromatin remodelling. In 44 
mammals, these ATP-dependent chromatin remodelling proteins usually exist within 45 
multiprotein complexes and play essential roles in the control of gene expression, DNA 46 
replication and repair (Hargreaves & Crabtree, 2011, Hota & Bruneau, 2016, Narlikar et al., 47 
2013). 48 
NuRD (Nucleosome Remodelling and Deacetylation) is one such multiprotein complex 49 
which is unique in that it contains both chromatin remodelling and protein deacetylase 50 
activity. NuRD is highly conserved amongst metazoans and has been shown to play 51 
important roles in cell fate decisions in a wide array of systems (Denslow & Wade, 2007, 52 
Signolet & Hendrich, 2015). For example, in embryonic stem (ES) cells NuRD controls 53 
nucleosome positioning at regulatory sequences to finely tune gene expression (Bornelov et 54 
al., 2018, Reynolds et al., 2012) and in somatic lineages NuRD activity has been shown to 55 
prevent inappropriate expression of lineage-specific genes to ensure fidelity of somatic 56 
lineage decisions (Denner & Rauchman, 2013, Gomez-Del Arco et al., 2016, Knock et al., 57 
2015, Loughran et al., 2017). It was recently demonstrated that this is achieved in both ES 58 
cells and B-cell progenitors by restricting access of transcription factors to regulatory 59 
sequences (Bornelov et al., 2018, Liang et al., 2017, Loughran et al., 2017). Additionally, 60 
aberrations in expression levels of NuRD component proteins are increasingly being linked 61 
to cancer progression (Lai & Wade, 2011, Mohd-Sarip et al., 2017). 62 
NuRD is comprised of two enzymatically and biochemically distinct subcomplexes: a 63 
chromatin remodelling and a deacetylase subcomplex. The chromatin remodelling 64 
subcomplex contains a nucleosome remodelling ATPase protein (Chd3/4/5) along with one 65 
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of the zinc finger proteins Gatad2a/b and the Doc1/Cdk2ap1 protein, while the deacetylase 66 
subcomplex contains class I histone deacetylase proteins Hdac1/2, the histone chaperones 67 
Rbbp4/7, the Metastasis Tumour Antigen family of proteins, Mta1, Mta2 and Mta3 and, in 68 
pluripotent cells, the zinc finger proteins Sall1/4 (Allen et al., 2013, Bode et al., 2016, Kloet 69 
et al., 2015, Lauberth & Rauchman, 2006, Low et al., 2016, Miller et al., 2016, Spruijt et al., 70 
2016, Zhang et al., 2016). These two subcomplexes are bridged by Mbd2/3, creating intact 71 
NuRD (Fig. 1A). While HDAC and RBBP proteins are also associated with other chromatin 72 
modifying complexes, the MBD, GATAD2 and MTA proteins are obligate NuRD components. 73 
Functional and genetic data indicate that the CHD4-containing remodelling subunit is 74 
capable of functioning independently of intact NuRD (O'Shaughnessy & Hendrich, 2013, 75 
O'Shaughnessy-Kirwan et al., 2015, Ostapcuk et al., 2018). The deacetylase subcomplex has 76 
been shown biochemically to exist outside of intact NuRD, though whether this subcomplex 77 
has any specific function is not clear (Link et al., 2018, Zhang et al., 2018). 78 
Changes in subunit composition in large multiprotein, chromatin modifying complexes 79 
such as PRC1 and BAF have been shown to correlate with distinct changes in function to 80 
sites of action in the chromatin in a cell-type specific manner (Ho & Crabtree, 2010, Morey 81 
et al., 2012). The NuRD complex might therefore be expected to show similar diversity in 82 
both composition and function and in fact, diversification of NuRD function has been 83 
described through differential incorporation of various isoforms of NuRD component 84 
proteins (Bowen et al., 2004). For example, Mbd2 and Mbd3 are mutually exclusive within 85 
NuRD (Le Guezennec et al., 2006). While Mbd2 is not required for mammalian development, 86 
Mbd3 is essential at early postimplantation stages in mice (Hendrich et al., 2001). 87 
Mbd2/NuRD is a methyl-CpG binding co-repressor complex which is dispensable for early 88 
development but Mbd3/NuRD, a transcriptional modulator found at sites of active 89 
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transcription, has been shown to play important roles in regulation of cell fate decisions in 90 
multiple developmental systems (Feng & Zhang, 2001, Gunther et al., 2013, Menafra et al., 91 
2014, Reynolds et al., 2012, Reynolds et al., 2013, Shimbo et al., 2013). NuRD complexes 92 
containing either CHD3, CHD4 or CHD5 play distinct roles during cortical development 93 
(Nitarska et al., 2016). 94 
Further functional and biochemical diversification occurs through alternate use of the 95 
three MTA proteins within NuRD. MTA proteins function as a scaffold around which the 96 
deacetylase subcomplex is formed, comprising a 2:2:4 stoichiometry of MTAs:HDACs:RBBPs 97 
(Millard et al., 2016, Millard et al., 2013, Smits et al., 2013, Zhang et al., 2016). While 98 
invertebrates predominantly have a single MTA protein orthologue, most vertebrates have 99 
three. The three mammalian MTA proteins are highly conserved, differing from each other 100 
predominantly at their C-termini. The MTA1 protein was originally identified because of its 101 
elevated expression in metastatic cell lines (Toh et al., 1994), and subsequently all three 102 
MTA proteins have been shown to be up-regulated in a range of different cancer types 103 
(Covington & Fuqua, 2014, Ma et al., 2016, Sen et al., 2014). The MTA1 and 3 proteins were 104 
shown to form distinct NuRD complexes in breast cancer cells and in B-cells and were 105 
recruited by different transcription factors to regulate gene expression (Fujita et al., 2004, 106 
Fujita et al., 2003, Mazumdar et al., 2001, Si et al., 2015). These studies did not detect 107 
biochemical interactions between MTA3 and the other MTA proteins, leading to the 108 
conclusion that MTA proteins are mutually exclusive within NuRD. In contrast, Mta1 was 109 
shown to interact with Mta2 in MEL cells, possibly indicating that mutual exclusivity may be 110 
cell type-specific (Hong et al., 2005). While all three Mta genes are expressed in ES cells, 111 
detailed biochemical analysis of interactions of MTA proteins with one another or with the 112 
various NuRD components in ES cells has not previously been described.  113 
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Functional evidence does not support a strict lack of redundancy amongst MTA 114 
proteins during mammalian development. While zygotic deletion of Chd4 or Mbd3 results in 115 
pre- or peri-implantation developmental failure respectively (Kaji et al., 2007, 116 
O'Shaughnessy-Kirwan et al., 2015), mice deficient in any one of the three MTA proteins 117 
show minimal phenotypes. Mice lacking either Mta1 or Mta3 are viable and fertile 118 
(Manavathi et al., 2007)(Mouse Genome Informatics), while mice lacking Mta2 show 119 
incompletely penetrant embryonic lethality and immune system defects (Lu et al., 2008). In 120 
the current study we took a systematic approach to dissecting MTA protein biochemical and 121 
functional diversity. We find that, in contrast to what has been described in somatic cells, 122 
MTA proteins are not mutually exclusive within NuRD in ES cells and serve largely redundant 123 
functions. Furthermore, ES cells lacking all three MTA proteins are viable and represent a 124 
complete NuRD null, allowing us to identify a previously undetected function for NuRD in 125 
early stages of lineage commitment. 126 
 127 
Results 128 
MTA proteins are not mutually exclusive within the NuRD complex in ES cells 129 
The absence of a detected interaction between the MTA2 and MTA3 proteins in 130 
human cells (Fujita et al., 2003, Si et al., 2015), and the observation that different MTA 131 
proteins can show different protein-protein interactions in B-cells (Fujita et al., 2004) has led 132 
to the conclusion that the MTA proteins are mutually exclusive within NuRD, and could 133 
hence confer functional diversity to the NuRD complex (Lai & Wade, 2011). To investigate 134 
the biochemical specificity of the MTA proteins in an unbiased manner, we used gene 135 
targeting of endogenous loci to produce three different mouse ES cell lines in which an 136 
epitope tag was fused to the C-terminus of each MTA protein (Fig. 1A). Although MTA genes 137 
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show different expression patterns in preimplantation mouse development, all three are 138 
expressed in peri implantation and early post implantation epiblast, the tissue most similar 139 
to the naïve ES cell state (Fig. EV1). We therefore considered ES cells to be a good system in 140 
which to investigate the function of MTA proteins. 141 
Each tagged protein was expressed at levels comparable to those of wild type proteins 142 
and was found to interact with other NuRD component proteins by immunoprecipitation 143 
(Fig. 1B). Each MTA protein was also able to immunoprecipitate the other MTA proteins in 144 
addition to unmodified forms of itself (Fig. 1B). Mta3 was barely detectable in Mta1-3xFLAG 145 
immunoprecipitates by IP-western blot (though robustly found by mass spectrometry, see 146 
below), but Mta1 was robustly detected associating with Mta3-3xFLAG (Fig. 1B). This could 147 
indicate that any Mta1-Mta3 containing NuRD complexes represent a relatively small 148 
proportion of nuclear Mta1, but a relatively large proportion of nuclear Mta3. Individual 149 
NuRD complexes contain two MTA proteins (Millard et al., 2013, Smits et al., 2013, Zhang et 150 
al., 2016), so the identification of an interaction between MTA proteins means that NuRD 151 
complexes in ES cells could contain either homodimers or heterodimers consisting of any 152 
combination of the three MTA proteins.  153 
To investigate the potential biochemical diversification conferred by different MTA 154 
proteins in pluripotent cells we used our tagged cell lines to identify proteins interacting 155 
with each of the MTA proteins by label-free quantitative mass spectrometry. Each protein 156 
robustly co-purified with all known NuRD component proteins, including each of the MTA 157 
proteins, confirming that MTA proteins are not mutually exclusive within NuRD in ES cells 158 
(Fig. 1C). In addition to NuRD components, each of the MTA proteins co-purified with Wdr5 159 
as well as a number of zinc finger proteins, most of which had previously been identified as 160 
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NuRD-interacting proteins (Bode et al., 2016, Ee et al., 2017, Matsuura et al., 2017, Spruijt et 161 
al., 2016).  162 
As NuRD is assembled from a deacetylase subcomplex and a remodeller subcomplex 163 
joined through the Mbd3 protein (Fig. 1A), loss of Mbd3 is expected to result in dissociation 164 
of these two subcomplexes. Endogenous tagging for each Mta protein was performed in an 165 
ES cell line harbouring a floxed Mbd3 allele, and IP/Mass spectrometry was repeated in ES 166 
cells after Mbd3 deletion in order to enrich for interactions specific for the deacetylase 167 
subcomplex. The majority of interactions with non-NuRD components was lost after Mbd3 168 
deletion, indicating that most of these proteins do not directly associate with either the 169 
MTA proteins or with the deacetylase subcomplex (Fig. 1C). Exceptions to this were Zfp296, 170 
which was identified as interacting with all three MTA proteins in an Mbd3-independent 171 
manner, and Pwwp2a, which co-purified with Mta1 in both wild type and Mbd3-null cells, 172 
consistent with recent reports (Link et al., 2018, Zhang et al., 2018). Notably, Zfp219 and 173 
Zfp512b both showed Mbd3-independent interactions specifically with Mta2 (Fig. 1C).  174 
By quantitating the abundance of peptides sequenced in each experiment we found 175 
that the interactomes for both Mta1 and Mta2 showed a depletion of peptides associated 176 
with the remodeller subcomplex (i.e. Chd4, Gatad2a/b and Cdk2ap1) in Mbd3-null cells, 177 
whereas proteins associated with the histone deacetylase subcomplex (Mta proteins, 178 
Hdac1/2, Sall proteins and Rbbp4/7) remained present at similar levels (Fig 1D). In contrast 179 
the Mta3 interactome showed an increased interaction with Mbd2 and no relative loss of 180 
either sub-complex in the absence of Mbd3. Thus both Mta1 and Mta2 can form part of a 181 
stable histone deacetylase-containing subcomplex in the absence of intact NuRD, but Mta3 182 
is preferentially found in intact NuRD complexes. All three MTA proteins associated with 183 
Mbd2 in the absence of Mbd3, indicating that they can all can contribute to Mbd2/NuRD. 184 
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Together these data show that the MTA proteins are found exclusively within the NuRD 185 
complex in ES cells.  186 
 187 
MTA proteins show subtle differences in genome-wide binding patterns 188 
To test whether MTA proteins confer differential chromatin binding to NuRD 189 
complexes we subjected our ES cell lines expressing epitope-tagged MTA proteins to 190 
chromatin immunoprecipitation followed by high throughput sequencing (ChIP-Seq). The 191 
binding profiles of the three proteins were largely, but not completely overlapping (Fig. 2A, 192 
B). Mta3 binding was almost entirely associated with Mta1 and/or Mta2-binding, while 31% 193 
of Mta1 peaks and 22% of Mta2 peaks were not associated with any other MTA protein (Fig. 194 
2A,B). The overall efficiency of Mta3-3xFLAG ChIP-seq was lower than those for Mta1-195 
3xFLAG or Mta2-GFP, possibly due to the lower levels of Mta3 present in ES cells, although 196 
replicates were highly correlated (Appendix Figure S1). While Mta3-bound sites can 197 
therefore be identified with high confidence, it remains formally possible that “Mta1-only” 198 
or “Mta2-only” sites also contain Mta3, albeit at levels beneath the detection threshold of 199 
our ChiP-seq. The vast majority of MTA peaks were also bound by Chd4, indicating that they 200 
represent NuRD-bound regions (Fig. 2C, D; Fig. EV2A, B).  201 
Sites found associated with all three MTA proteins were highly enriched for Chd4 and 202 
Mbd3 binding, consistent with these being core NuRD binding regions (Fig. 2D). These sites 203 
were also enriched for marks of active promoters (H3K4Me3, H3K27Ac) and active 204 
enhancers (H3K4Me1, H3K27Ac, P300; Fig. 2D, E), both of which are hallmarks of NuRD-205 
associated regions (Bornelov et al., 2018, Miller et al., 2016). The same was true for sites 206 
bound by any two of the three MTA proteins (Fig. EV2B). The majority of sites occupied by 207 
one MTA protein, but not the other two, were also occupied by Chd4 but to a lesser extent 208 
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than is seen at core NuRD sites (Fig. 2D, E). Sites associated with all three MTA proteins, 209 
presumably representing core NuRD-bound sites, were located both at transcription start 210 
sites and at distal locations, while sites bound by only one MTA protein were predominantly 211 
located distal to transcription start sites (Fig EV2C). Whereas Mta2-only and Mta3-only sites 212 
showed some enrichment for both H3K4Me1 and H3K4Me3, Mta1-only sites showed no 213 
enrichment for H3K4Me3 (Fig. 2D, E). In all cases MTA-only sites lacking Chd4, which could 214 
represent sites of binding by the histone deacetylase subcomplex only, showed 215 
characteristics of inactive enhancers, in that they were moderately enriched for H3K4Me1 216 
and P300, but not for H3K4Me3, H3K27Ac or H3K36Me3 (Fig EV2D). None of the MTA-217 
bound sequences showed any enrichment for methylated DNA (Fig. EV2E). Genes associated 218 
with binding by only one or two MTA proteins, with or without Chd4 are associated with a 219 
similar distribution of GO terms (Fig EV2F) which is not consistent with the idea that the 220 
MTA proteins are directing NuRD activity to specific gene subsets.  221 
 222 
Mta1/Mta2/Mta3 triple knockout is a total NuRD null 223 
To investigate the degree of genetic redundancy amongst the different MTA genes, 224 
we obtained gene trap alleles for each gene from the European Conditional Mouse 225 
Mutagenesis Programme (Skarnes et al., 2011) as ES cell lines (Mta1 and Mta2) or as 226 
embryos (Mta3) (Fig. EV3A-C). ES cell lines were used for morula aggregation to create 227 
chimaeric mice which were subsequently outcrossed to establish a mouse line. Conditional 228 
deletion alleles were generated for each line, which was subsequently bred with females 229 
expressing Sox2-Cre (Hayashi et al., 2002) resulting in deletion of floxed exons and the 230 
absence of any detectable protein production from each allele (Fig. EV3D; see Methods for 231 
details). As has been reported previously, Mta1-/- and Mta3-/- mice were viable, and Mta2-/- 232 
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mice showed incompletely penetrant embryonic lethality (Lu et al., 2008, Manavathi et al., 233 
2007).  234 
Mta1, Mta2 or Mta3-null ES cell lines derived from mice were morphologically 235 
indistinguishable from wild type ES cells, as were ES cell lines deficient for combinations of 236 
pairs of MTA genes (Fig. EV3E). While some differences in gene expression could be 237 
identified between single mutants and their respective parent lines (Fig EV3F, G), these 238 
changes were not sufficient to make them distinct from wild type ES cells when compared 239 
to Mbd3-mutant ES cells, 3.5 dpc ICM and 4.5 dpc epiblast (Fig EV3H). We therefore 240 
concluded that any gene expression changes identified in single mutant ES cells were 241 
unlikely to be of consequence during early development, and that MTA proteins show 242 
functional redundancy during early mammalian development.  243 
Mta1-/-Mta2-/-Mta3Flox/Flox ES cells (Mta12∆) were subsequently created and expanded 244 
in culture. After transfection with a Cre expression construct to induce deletion of both 245 
Mta3 alleles we recovered ES cells lacking all three MTA proteins (see Methods for details; 246 
Fig. 3A). These Mta1-/-Mta2-/-Mta3-/- ES cells (subsequently referred to as Mta123∆) 247 
appeared morphologically normal in standard, 2i + LIF culture (Fig. 3B), but showed a 248 
considerable degree of spontaneous differentiation in serum/LIF culture. MTA proteins are 249 
therefore dispensable for ES cell viability. 250 
Structurally, MTA proteins bridge an interaction between the deacetylase subcomplex 251 
with Mbd3 and the remodelling subcomplex (Fig. 1A) so we predicted that loss of all three 252 
MTA proteins would prevent NuRD formation. Consistent with this prediction we could 253 
detect no interactions between Chd4 and components of the deacetylase subcomplex 254 
(Hdac2, Rbbp4) in Mta123∆ ES cell nuclear extract by immunoprecipitation of endogenous 255 
proteins (Fig. 3C). Surprisingly, despite being transcribed at normal levels, both Gatad2b and 256 
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Mbd3 proteins were present at reduced levels in Mta12∆ cells and barely detectable in 257 
Mta123∆ cells (Fig. 3C; Fig. EV4A), indicating that the MTAs are important for the stability of 258 
both of these proteins. To investigate this further we monitored loss of protein stability in 259 
Mta1∆/∆Mta2∆/∆Mta3Flox/Flox ES cells after deletion using a tamoxifen-inducible Cre (Fig. 3D). 260 
Loss of Mbd2, Mbd3, Gatad2a and Gatad2b protein stability were all coincident with loss of 261 
Mta3 protein, although Mbd3 and Gatad2b were already at reduced levels in the starting 262 
cell line (Mta12∆Mta3Flox/Flox) (Fig. 3D). Gatad2b and Mta3 also show reduced protein 263 
stability in Mbd3∆ ES cells, indicating that a particular inter-dependency exists between 264 
these three proteins for stability (Fig EV4B). Furthermore, introduction of either Mta1, Mta2 265 
or Mta3 into Mta123∆ ES cells at levels comparable to wild type expression resulted in 266 
restoration of Mbd3 protein levels, demonstrating that contact with at least one of the MTA 267 
proteins is sufficient for Mbd3 protein stability (Fig. 3E). In contrast to Mbd3-null ES cells 268 
which display a significant depletion, but not a complete loss of NuRD due to partial 269 
compensation by Mbd2 (Kaji et al., 2006), Mta123∆ ES cells were completely devoid of any 270 
detectable intact NuRD (Fig. 3C, F). The Mta123∆ ES cells are thus a total NuRD null ES cell 271 
line, which allowed us to examine, for the first time, the consequences of a complete loss of 272 
the NuRD complex in a viable mammalian cell system. 273 
 274 
NuRD suppresses transcriptional noise 275 
Twice as many genes showed an increase rather than a decrease in expression levels 276 
in Mta123∆ ES cells compared to control ES cells by RNA-seq (Fig. 4A). The ratio of increased 277 
to decreased gene expression in Mta123∆ cells was very similar for genes bound by all three 278 
Mta proteins, Mta1+2, Mta1 only or Mta2 only (Fig. 4B). NuRD’s global impact on 279 
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transcription is therefore not grossly altered by the inclusion or absence of individual MTA 280 
subunits. 281 
Comparing global gene expression profiles using principal component analysis (PCA) 282 
showed that Mta123∆ and Mbd3∆ ES cells in self-renewal conditions were more similar to 283 
each other than either was to wild type cells (Fig. 4C). Mta123∆ ES cells were most distinct 284 
from wild type cells, consistent with them representing a more complete NuRD knockout 285 
(Fig. 4C). Consistent with this, genes driving the NuRD-specific separation (Principal 286 
Component 2; PC2) were generally misexpressed to a greater degree in Mta123∆ ES cells 287 
than in Mbd3∆ ES cells (Fig EV4C). Genes misexpressed in either Mbd3∆ or Mta123∆ ES cells 288 
were most significantly associated with the same top three GO terms, but the significance 289 
was greater in Mta123∆ ES cells as these cells misexpressed more genes in each category 290 
and generally to a greater extent than did the Mbd3∆ cells (Fig. 4D, E, EV4C). 291 
Genes misexpressed in Mta123∆ ES cells were predominantly those normally 292 
expressed at lower levels (Fig. EV4D). A very similar pattern was seen if we considered genes 293 
misexpressed in Mbd3∆ ES cells, with the major difference being that more genes were 294 
misexpressed in the Mta123∆ cells. The predominant biochemical difference between the 295 
Mbd3∆ cells and Mta123∆ cells was the lack of Mbd2/NuRD and of the MTA/HDAC 296 
subcomplex in the triple mutants, so we next asked whether we could detect evidence for 297 
specific functions for either of these complexes in ES cells. We identified genes near core 298 
NuRD peaks (N=15210), near Mta-only peaks (regardless of the presence of a NuRD peak; 299 
N=10280), genes associated with NuRD components Chd4 and MTAs, but not Mbd3 300 
(presumptive Mbd2/NuRD-only genes; N=349), and genes containing MTA-only peaks, but 301 
no Chd4 peak (MTA-only genes; N=151) (Fig. 4F) and divided them into expression quartiles. 302 
While there are very few genes not associated with a NuRD peak, those few presumptive 303 
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Mbd2/NuRD-only genes or MTA-only genes showed a similar misexpression pattern to 304 
those seen for core NuRD genes, in that the majority of misexpressed genes was in the 305 
second lowest expression quartile (Fig. 4F). We therefore find no evidence for a specific 306 
gene regulatory function associated with an MTA/HDAC subcomplex. This is consistent with 307 
a recent report in which loss of Pwwp2a/b resulted in only very slight alterations in nascent 308 
RNA production amongst a small subset of genes (Zhang et al., 2018). Nevertheless, this 309 
analysis further highlights the importance for NuRD in suppressing expression of lowly 310 
expressed genes. We therefore conclude that, in addition to fine-tuning gene expression as 311 
part of the Mbd3/NuRD complex, MTA proteins are also important for preventing 312 
inappropriate activation of a variety of different genes, or in preventing transcriptional noise 313 
in ES cells. 314 
 315 
The NuRD complex safeguards cellular identity during differentiation  316 
We next asked what impact complete loss NuRD activity had upon the differentiation 317 
capacity of Mta123∆ ES cells. Upon removal of the two inhibitors and LIF from the culture 318 
media wild type cells began to adopt the flatter morphology of neurectoderm (Fig. 5A)(Ying 319 
et al., 2003). This was accompanied by downregulation of pluripotency-associated genes 320 
and the activation of a neural gene expression programme (Fig. 5B). Mbd3∆ ES cells are able 321 
to respond to the absence of self-renewal factors but have a very low probability of 322 
adopting a differentiated fate when induced to differentiate in N2B27 conditions (Kaji et al., 323 
2006, Reynolds et al., 2012). Consistent with these findings, after 5 days in differentiation 324 
conditions Mbd3∆ ES cells showed some signs of having responded to differentiation 325 
conditions, but still retained pockets of morphologically undifferentiated cells (Fig. 5A, 326 
Middle). In contrast the completely NuRD-null Mta123∆ ES cells appeared to have all exited 327 
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the self-renewal programme and adopted a flat, monolayer morphology (Fig. 5A, Bottom). 328 
The ability of Mta123∆ ES cells to undergo morphologically normal neuroectodermal 329 
differentiation was rescued upon re-expression of either Mta1, Mta2 or Mta3 (Fig. EV5A).  330 
Since the differentiation process may be considered as a combination of exit from self-331 
renewal (downregulation of pluripotency-associated genes) and acquisition of lineage 332 
specific gene expression programs, we focussed on changes to these two classes of genes by 333 
RT-qPCR over a differentiation time course. Pluripotency-associated genes such as Esrrb, 334 
Nanog and Pou5f1 were downregulated during differentiation of wild type, Mbd3∆ and 335 
Mta123∆ ES cells (Fig. 5B). While this downregulation was not absolutely dependent on the 336 
presence of functional NuRD, the magnitude and kinetics of the response varied in a gene-337 
dependent manner. Genes associated with acquisition of neural fate such as Nestin, Pax6, 338 
Ascl1 and Cdh2 were activated in the presence of wild type NuRD, but this response was 339 
reduced or absent in the NuRD mutant lines (Fig. 5B). In contrast, Mta123∆ ES cells 340 
aberrantly expressed markers of inappropriate lineages, such as Elf5 and Gata3 341 
(trophectoderm—but not Cdx2 or Eomes), Ebf4, Nobox and Hcn4 (genes associated more 342 
generally with later stages of differentiation or transmembrane transport). Misexpression of 343 
these genes was also seen in Mbd3∆ cells, although not always to the same extent. 344 
Exogenous expression of either Mta1, Mta2 or Mta3 was able to rescue the ability of 345 
Mta123∆ ES cells to activate neural gene expression to different extents during 346 
differentiation (Fig. EV5B), consistent with their ability to rescue morphological phenotypes.  347 
The morphology of Mta123∆ cells induced to differentiate towards neuroectoderm 348 
was quite different from that of Mbd3∆ cells (Fig. 5A), but there was no large-scale 349 
difference in gene categories changing between the two mutant lines after 48h in 350 
differentiation conditions (Fig. EV5C). In general Mta123∆ cells misexpressed more genes 351 
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from each category and to a greater extent than did Mbd3∆ cells (Fig EV5D), indicating that 352 
their abnormal morphology in differentiation conditions is most likely due to widespread 353 
gene misexpression generally, rather than activation of a specific differentiation pathway. 354 
Mta123∆ ES cells induced to differentiate towards a mesoderm fate similarly failed to 355 
appropriately activate differentiation markers, and exogenous expression of individual MTA 356 
proteins was again able to rescue the defect to varying degrees (Fig. EV5E).  357 
To assess the differentiation potential of Mta123∆ ES cells in an unbiassed manner, 358 
we allowed control, Mbd3∆ and Mta123∆ ES cells to differentiate in embryoid bodies in 359 
basal media supplemented with serum (Doetschman et al., 1985). After 12 days control cells 360 
had formed colonies containing numerous morphologically distinguishable cell types, 361 
silenced pluripotency-associated gene expression and activated expression of genes 362 
associated with all three germ layers (Fig. 5C, D). In contrast both Mbd3∆ and Mta123∆ cells 363 
showed less vigorous outgrowths consisting predominantly of a monolayer of flat cells (Fig. 364 
5C). While both mutant lines were able to silence expression of pluripotency-associated 365 
genes, both showed reduced activation of differentiation-associated genes, with Mta123∆ 366 
cells generally showing more profound expression defects than Mbd3∆ cells (Fig. 5D). 367 
Together these data show that while NuRD is not strictly required for silencing of 368 
pluripotency genes, its activity is required for proper activation of lineage-appropriate genes 369 
and repression of lineage-inappropriate genes during differentiation. 370 
To better understand how NuRD-null cells respond when induced to differentiate we 371 
compared their gene expression profiles to a transcription landscape made from single cells 372 
taken from early mouse embryos (Fig. 5E; EV5F, G) (Mohammed et al., 2017). In the self-373 
renewing state, Mbd3 and Mta123 cells clustered near control (parental) lines near 374 
embryonic day 3.5 (E3.5) and E4.5 inner cell mass cells, as is expected for naïve mouse ES 375 
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cells (Boroviak et al., 2014). After 48 hours of differentiation control ES lines clustered with 376 
E5.5 epiblast cells, indicating that the ES cell differentiation process occurred analogously to 377 
development in vivo. While Mbd3 ES cells appear to have exited the self-renewing state 378 
and to have taken the same differentiation trajectory as wild type cells (i.e. leftwards along 379 
PC1; Fig 5E, EV5G), they did not travel as far along this trajectory as wild type cells, instead 380 
occupying a space between the E4.5 and E5.5 epiblast states. Mta123 cells travelled even 381 
less far along PC1 than Mbd3∆ ES cells, and rather than maintain the appropriate 382 
differentiation trajectory they also travelled along PC2, occupying a space between E4.5 383 
epiblast and E4.5 primitive endoderm. This further demonstrates that not only is NuRD 384 
important for cells to be able to adopt the appropriate gene expression programme for a 385 
given differentiation event, but it is also important for cells to maintain an appropriate 386 
differentiation trajectory.  387 
If Mta123∆ ES cells were undergoing a specific trans-differentiation event towards 388 
trophectoderm during ES cell differentiation then this could become more pronounced if 389 
exposed to normal differentiation conditions in a chimaeric embryo. If, in contrast, they are 390 
simply unable to differentiate properly, they would not be expected to contribute to early 391 
embryos. To distinguish between these possibilities, we assessed the ability of Mta123∆ ES 392 
cells to differentiate in chimaeric embryos. Equal numbers of control or Mta123∆ ES cells 393 
expressing a fluorescent marker were aggregated with wild type morulae and allowed to 394 
develop for 48 hours. While wild type cells contributed to the ICM of host embryos with 395 
100% efficiency, Mta123∆ ES cells showed significantly reduced contribution and increased 396 
levels of apoptosis (Fig. 6A-B, EV5H). Those Mta123∆ cells that did survive in blastocysts 397 
were predominantly, but not always found in the inner cell mass. These cells expressed Sox2 398 
but not Cdx2, indicating that they had not undergone inappropriate differentiation towards 399 
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a trophectoderm fate (Fig. 6A, B). Nevertheless, no Mta123∆ cells could be found in E5.5 400 
dpc embryos, indicating that they were unable to adapt to developmental cues and form 401 
epiblast. This is most consistent with Mta123∆ cells being unable to enter a normal 402 
differentiation path in an ICM environment. The ability to contribute to the ICMs of 403 
chimaeric embryos was rescued by constitutive expression of Mta2 in Mta123∆ cells (Fig. 404 
6B). We therefore propose that NuRD functions not only to establish the correct lineage 405 
identity of cells during the differentiation process, but also prevents inappropriate gene 406 
expression to maintain an appropriate differentiation trajectory (Fig. 6C). 407 
  408 
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Discussion 409 
Here we provide a biochemical and genetic dissection of the core NuRD component 410 
MTA proteins in mouse ES cells. In contrast to what has been found in somatic cell types, 411 
MTA proteins are not mutually exclusive in ES cell NuRD complexes and all combinations of 412 
MTA homo- and hetero-dimers can exist within NuRD. Different MTA proteins exhibit subtle 413 
differences in chromatin localisation or biochemical interaction partners, but we find no 414 
evidence for protein-specific functions in self-renewing or differentiating mouse ES cells. ES 415 
cells completely devoid of MTA proteins are complete NuRD nulls and are viable but show 416 
inappropriate expression of differentiation-associated genes, are unable to maintain an 417 
appropriate differentiation trajectory and do not contribute to embryogenesis in chimaeric 418 
embryos. 419 
Protein subunit diversity is often found in chromatin remodelling complexes which 420 
specifies functional diversity (Hargreaves & Crabtree, 2011, Hota & Bruneau, 2016, Morey et 421 
al., 2012). This is also the case for the NuRD complex, where alternate usage of Mbd2/3, 422 
Chd3/4/5, and Mta1/2/3 has been found to result in alternate functions for NuRD 423 
complexes (Feng & Zhang, 2001, Fujita et al., 2003, Nitarska et al., 2016). Yet our findings 424 
that Mta1 and Mta3-null mice are viable and fertile, and that we detect no major 425 
differences in the abilities of different MTA proteins to rescue the Mta123∆ ES cell 426 
phenotypes indicates that MTA proteins exhibit considerable functional redundancy during 427 
development. The MTA protein family expanded from a single copy to three orthologues 428 
near the base of the vertebrate clade. Triplication of this protein family may have allowed 429 
early vertebrates to diversify NuRD function in specific somatic tissues, conferring a 430 
selective advantage. Our finding that MTA proteins are functionally redundant in early 431 
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embryonic development indicates that the ancestral, essential function of the MTA proteins 432 
in early development has been retained by all three mammalian orthologues.  433 
Different MTA proteins are capable of interacting with each other in ES cells, so how 434 
the mutual exclusivity reported in other cell types might be achieved is not clear. One 435 
possibility is that the variable inclusion in NuRD of zinc finger proteins, such as the Sall 436 
proteins in ES cells, could influence the MTA makeup of NuRD complexes. This class of 437 
variable NuRD interactors, which include Sall1/2/3/4, Zfp423 (Ebfaz), Zfpm1/2 (Fog1/2), and 438 
Bcl11b, interact with RBBP and/or MTA proteins via a short N-terminal motif (Hong et al., 439 
2005, Lauberth & Rauchman, 2006, Lejon et al., 2011). Of this class of proteins Sall1 and 440 
Sall4 are the most highly expressed in ES cells, and Sall4 can associate with all three MTA 441 
proteins (Fig. 1C) (Miller et al., 2016). In contrast the Zfpm1 (Fog1) protein was shown to 442 
preferentially associate with Mta1 and Mta2, but not Mta3, in a somatic cell line (Hong et 443 
al., 2005). Hence it is possible that different proteins using this N-terminal motif to interact 444 
with NuRD in different cell types could act to skew the proportion of different MTA proteins 445 
included in the NuRD complex.  446 
This genetic dissection has revealed that NuRD component proteins display a large 447 
degree of inter-dependence for protein stability, as has been reported for other 448 
multiprotein complexes (Roumeliotis et al., 2017). Mta1 and Mta2 both contain two distinct 449 
RBBP interaction domains, while Mta3 lacks the C-terminal most RBBP interaction domain 450 
(Millard et al., 2016). The Mta1 and Mta2 proteins show minimal loss of stability in the 451 
absence of Mbd3, but Mta3 requires an interaction with Mbd3 to be completely stable (Fig. 452 
EV4B) (Bornelov et al., 2018). It is possible that the additional interaction with an Rbbp 453 
protein confers stability to Mta1 and Mta2 in the absence of Mbd3. This would be 454 
consistent with our interpretation that Mta3 preferentially exists within an intact NuRD 455 
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complex (Figs 1, 2). Rbbp4/7 confer histone H3 binding to the NuRD complex, so Mta3-456 
containing NuRD may bind chromatin less tightly than Mta1- and/or Mta2-containing NuRD.  457 
We have used pluripotent cells lacking Mbd3 extensively to show that NuRD plays 458 
important roles in control of gene expression during early stages of exit from pluripotency in 459 
vivo and in culture (Kaji et al., 2006, Kaji et al., 2007, Latos et al., 2012, Reynolds et al., 460 
2012). Mbd3-null ES cells contain Mbd2/NuRD and thus represent a NuRD hypomorph, 461 
rather than a NuRD-null. ES cells lacking all three MTA proteins show no detectable NuRD 462 
formation (Fig. 3) and therefore we propose represent a true NuRD null. Mta123∆ ES cells 463 
are similar to Mbd3∆ ES cells in that both misexpress a range of genes in 2iL conditions and 464 
both fail to properly differentiate. Yet the Mta123∆ ES cells misexpress more genes and 465 
generally to a greater extent than do Mbd3∆ cells in both self-renewing and differentiation 466 
conditions, and they show more pronounced differentiation defect. We propose that this 467 
phenotype is a direct consequence of NuRD’s function in suppressing transcriptional noise 468 
during cell fate decisions. Moderate amounts of noise in the Mbd3∆ state allows cells to 469 
maintain a differentiation trajectory, but interferes with their ability to achieve the 470 
appropriate differentiation state (Fig. 6C). In the higher levels of noise characteristic of a 471 
complete absence of NuRD cells are unable to appropriately follow differentiation cues and 472 
maintain a coherent differentiation trajectory (Fig. 6C). We therefore propose that NuRD 473 
encodes a highly conserved, redundant function to prevent transcriptional noise, as well as 474 
a further, Mbd3-dependent function to fine tune transcriptional outputs during 475 
differentiation. 476 
 477 
Materials and Methods 478 
Mouse embryonic stem cells 479 
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Mouse embryonic stem cells (ESCs) were grown on gelatin-coated plates in 2i/LIF 480 
conditions as described (Ying et al., 2008). All lines were routinely PCR genotyped and tested 481 
for mycoplasma. All ES cell lines used in this study are listed in Table EV1. 482 
The following “Knockout First” alleles were obtained from EUCOMM as heterozygous 483 
ES cell lines (Illustrated in Fig. EV1A, B): 484 
Mta1tm1a(EUCOMM)Wtsi 485 
https://www.mousephenotype.org/data/alleles/MGI:2150037/tm1a(EUCOMM)Wtsi 486 
Mta2tm1a(EUCOMM)Wtsi  487 
https://www.mousephenotype.org/data/alleles/MGI:1346340/tm1a(EUCOMM)Wtsi 488 
ES cells were used to derive mouse lines by blastocyst injection using standard 489 
methods. ESC derivation was performed by isolating ICMs and outgrowing in 2i/LIF media as 490 
described (Nichols et al., 2009). 491 
The epitope tagged ESC lines Mta1-Avi-3×FLAG and Mta2-GFP were generated by 492 
traditional gene targeting, while the Mta3-Avi-3×FLAG line was generated using a 493 
CRISPR/Cas9 genome editing approach. Mta3 contains three alternate stop codons in exons 494 
14, 16 and 17, with exon 15 accessed by alternate usage of a splice donor site in exon 14. 495 
Visual inspection of our RNAseq data on a genome browser showed very little transcription 496 
beyond exon 14 in ES cells, indicating that the short isoform was predominant (Appendix 497 
Figure S2). We therefore targeted the stop codon present in exon 14 and simultaneously 498 
destroyed the alternate splice donor site using a synonymous mutation (GAA TGT to GAA 499 
TGC) to prevent splicing around our inserted construct in the targeted allele. The following 500 
sequences were targeted by guide RNAs in this experiment: 5’-501 
GGCAAGGAGCGGAACGCGGA-3’ and 5’-GGATGGCAAGGAGCGGAACG-3’. All MTA epitope 502 
tagged lines were made in an Mbd3Flox/- background (Kaji et al., 2006).  503 
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Mta123∆ ES cells were made by targeting Mta2 in Mta1∆/∆ Mta3Flox/Flox ES cells. Guide 504 
RNAs targeting exons 2 and 18 of Mta2 were transfected along with a targeting construct 505 
designed to replace exons 2-18 with a puromycin expression cassette. The resulting ES cell 506 
lines had replaced exon 2-18 with the selection cassette on one allele, and had a deletion of 507 
the same exons on the other allele. The following sequences were targeted by guide RNAs: 508 
exon 2 (5’-TAGACGTAATCTGTAGGAGG-3’ and 5’-AAATAGACGTAATCTGTAGG-3’) and exon 509 
18 (5’-AAATGCGCCGAGCGGCCCGA-3’ and 5’-TCACCTGGAAATGCGCCGAG-3’). 510 
ES cells were induced to differentiate towards a neuroectoderm fate by removal of 511 
two inhibitors and LIF and culturing in N2B27 media as described (Ying et al., 2008). 512 
Mesendoderm differentiation was performed as follows: ES cells were plated at 104 513 
cells/cm2 in N2B27 on fibronectin-treated 6-well plates and cultured for 48 hours. Medium 514 
was then replaced with 10 ng/ml activin A and 3 µM CHIR99021 in N2B27 and cultured 515 
further. Embryoid bodies were allowed to form by allowing ~500 cells to aggregate in 516 
hanging drops of N2B27 media supplemented with 10% fetal calf serum. After 3 days 517 
embryoid bodies were allowed to attach and outgrow on gelatin-coated plates in N2B27 + 518 
serum. Experiments were carried out in quadruplicate. 519 
 520 
Mice 521 
All animal experiments were approved by the Animal Welfare and Ethical Review Body 522 
of the University of Cambridge and carried out under appropriate UK Home Office licenses. 523 
The Mta3 “Knockout First” allele was obtained from EUCOMM as a heterozygous mouse line 524 
(Illustrated in Fig. EV1C):  525 




Heterozygous knockout first mouse lines were crossed to a Flp-deletor strain kindly 529 
provided by Andrew Smith (University of Edinburgh) (Wallace et al., 2007) to generate 530 
conditional alleles. Mice harbouring conditional alleles were crossed to a Sox2-Cre 531 
transgenic line (Hayashi et al., 2002) to create null alleles. Mouse lines created in this study 532 
are listed in Table EV1. 533 
Chimaeric embryos were made by morula aggregation with 8-10 ES cells per embryo 534 
as described (Hogan et al., 1994) and cultured for 24-48 hours prior to fixation and 535 
immunostaining. ES cells used stably expressed a PiggyBac Kusabira Orange transgene. 536 
 537 
Nuclear Extracts and Immunoprecipitation  538 
For extraction of nuclear proteins, ES cells were lysed in ice cold Buffer A (10mM 539 
HEPES pH7.9, 1.5mM MgCl2, 10mM KCl, 0.5mM DTT) supplemented with protease inhibitors 540 
and containing 0.6% NP-40. Nuclear pellets were washed further with Buffer A to reduce 541 
cytoplasmic protein contamination before extraction by vigorous shaking at 4° C for 1 hour 542 
in ice cold Buffer C (10mM HEPES pH7.9, 12.5% glycerol, 0.75mM MgCl2, 10mM KCl, 0.5mM 543 
DTT) with protease inhibitors followed by centrifugation to remove insoluble fraction. 544 
For immunoprecipitation of Flag-tagged proteins, anti-Flag antibody was incubated 545 
with Protein G-Sepharose beads (Sigma) for 1h at room temperature. Nuclear extract (200 546 
µg) was diluted in IP-Buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-547 
100, 0.1% SDS, 0.1% DOC) in the presence of protease inhibitors and Benzonase and 548 
incubated with antibody-bead conjugates at 4° C overnight. Beads were washed three times 549 
in ice cold IP Buffer and a further two times in IP Buffer containing 300mM NaCl. 550 
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Chd4 immunoprecipitations were carried out at 4° C overnight using antibody to 551 
endogenous Chd4 with Protein G sepharose in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM 552 
EDTA, 1% Triton X-100, 10% glycerol and washed as for the Flag IPs before SDSPAGE. 553 
For immunoprecipitation of GFP-tagged proteins, Chromotek GFP-Trap agarose beads 554 
were used. Nuclear extract (200g ) was incubated with 25l GFP-Trap beads in GFP IP 555 
buffer (10mM Tris pH 7.5, 150mM NaCl, 0.5mM EDTA) with Benzonase and protease 556 
inhibitors for 1 hour at 4° C. Beads were washed five times in IP buffer prior to Western 557 
blotting. 558 
IPs were carried out in bulk and loaded on multiple SDS gels for Western blot analysis 559 
with various antibodies.  Antibodies are listed in Table EV2.  560 
 561 
Label-free pulldowns and label-free quantitation (LFQ) LC-MS/MS analysis 562 
Label-free GFP pulldowns were performed in triplicate as previously described (Kloet 563 
et al., 2018). 2 mg of nuclear extract was incubated with 7.5 μl GFP-Trap beads (Chromotek) 564 
or 15 μl Flag-sepharose beads (Sigma) and 50 μg/mL ethidium bromide in Buffer C (300 mM 565 
NaCl, 20 mM HEPES/KOH, pH 7.9, 20% v/v glycerol, 2 mM MgCl2, 0.2 mM EDTA) with 0.1% 566 
NP-40, protease inhibitors, and 0.5 mM DTT in a total volume of 400 μl. After incubation, 6 567 
washes were performed: 2 with Buffer C and 0.5% NP-40, 2 with PBS and 0.5% NP-40, and 2 568 
with PBS. Affinity purified proteins were subject to on-bead trypsin digestion as previously 569 
described (Smits et al., 2013). In short, beads were resuspended in 50 μl elution buffer (2 M 570 
urea, 50 mM Tris pH 7.5, 10 mM DTT) and incubated for 20 min in a thermoshaker at 1400 571 
rpm at room temperature. After addition of 50 mM iodoacetamide (IAA), beads were 572 
incubated for 10 min at 1400 rpm at room temperature in the dark. Proteins were then on-573 
bead digested into tryptic peptides by addition of 0.25 μg trypsin (Promega) and subsequent 574 
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incubation for 2 h at 1400 rpm at room temperature. The supernatant was transferred to 575 
new tubes and further digested overnight at room temperature with an additional 0.1 μg of 576 
trypsin. Tryptic peptides were acidified and desalted using StageTips (Smits et al., 2013) 577 
prior to mass spectrometry analyses. 578 
 579 
Chromatin immunoprecipitation (ChIP), sequencing, and analysis 580 
Chromatin immunoprecipitations were carried out as previously outlined (Reynolds et 581 
al., 2012). For sequencing of ChIP DNA, samples from six (Mta1-FLAG and Mta2-GFP) and 582 
four (Mta3-FLAG) individual ChIP experiments were used. Antibodies used are listed in Table 583 
EV2. ChIP-seq libraries were prepared using the NEXTflex Rapid DNA-seq kit (Illumina) and 584 
sequenced at the CRUK Cambridge Institute Genomics Core facility (Cambridge, UK) on the 585 
Illumina platform. Low-quality reads and adaptor sequences were removed by Trim Galore! 586 
(version: 0.4.1, https://github.com/FelixKrueger/TrimGalore). The trimmed ChIP-seq reads 587 
were aligned to the mouse reference genome (GRCm38/mm10) using bowtie (version: 588 
0.12.8; options: -m 1 -v 1) (Langmead, 2010). This was followed by peak calling using macs2 589 
callpeaks against the corresponding inputs using default parameters and a Q-value of < 590 
0.05. The R/Bioconductor Diffbind package was used to compare each combination of 591 
bound Mta proteins against all others using cut-off values of RPKM > 1.5, logFC > 1 and FDR 592 
< 0.05. The peaks were processed and visualized by deepTools computeMatrix and 593 
plotHeatmap (Ramirez et al., 2014). Venn diagrams were plotted using the R/Bioconductor 594 
ChIPseeker package. 595 
DNA Methylation data was obtained from (Shirane et al., 2016), low-quality reads and 596 
adaptor sequences were removed by Trim Galore! (version: 0.4.1), and reads were aligned 597 
to the mouse reference genome (GRCm38/mm10) using Bismark (version: 0.20.0)(Krueger & 598 
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Andrews, 2011). Alignments were de-duplicated and further processed using Methpipe. 599 
Only CpGs with a coverage of at least 3 reads were considered. CpG methylation levels were 600 
visualized by deepTools using a sliding window of 250 bp to give a smoothed track for the 601 
heatmaps and profiles. Sequencing datasets are listed in Table EV3. 602 
 603 
Gene expression analyses 604 
Total RNA was purified using RNeasy Mini Kit (Qiagen) including on-column DNase 605 
treatment. First-strand cDNA was synthesized using SuperScript IV reverse transcriptase 606 
(Invitrogen) and random hexamers. Quantitative PCR (qPCR) reactions were performed 607 
using TaqMan reagents (Applied Biosystems) on a QuantStudio Flex Real-Time PCR System 608 
(Applied Biosystems) or a StepOne Real-Time PCR System (Applied Biosystems). Gene 609 
expression was determined relative to housekeeping genes using the ΔCt method. TaqMan 610 
assays, or PCR primers are listed in Table 1. 611 
Table 1. List of TaqMan assays and primers used for gene expression analyses. 612 
Gene TaqMan assay  



















Ppia  Mm02342430_g1 






Gene Forward primer (5’ – 3’) Reverse primer (5’ – 3’) 
 
Ebf4 AACTGCGGGTCCTTATGTTC TTTGTCTTTTCCGTCCCAGG 
Hcn4 CCCGCCTCATTCGATACATT AGCAGAAGCATCATGCCAAT 
Nobox CCTACGGAGAAGCTCTGCAA TCTGGGGGAGAACAACCTTC 
Sfrp2 AATGAGGACGACAACGACAT ACGCCGTTCAGCTTGTAAAT 
 614 
RNA-seq 615 
Libraries for sequencing were prepared using the NEXTflex Rapid Directional RNA-seq 616 
kit (Illumina) or SMARTer® Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian (Takara 617 
Bio) and sequenced on the Illumina platform as for ChIP-seq libraries. Low-quality reads and 618 
adaptor sequences were removed by Trim Galore! (version: 0.4.1), and the trimmed reads 619 
were aligned to mouse reference genome (GRCm38/mm10) using Tophat (version v2.1.0, 620 
(Kim et al., 2013)). Read counts per gene were obtained using featureCounts  (version 1.5.0, 621 
(Liao et al., 2014) with annotations from Ensembl release 86 (Yates et al., 2016). 622 
Normalization, with and without spike-ins, and differential expression analyses were 623 
performed using the R/Bioconductor Deseq2 package (version 1.14.1, (Love et al., 2014)). 624 
The R prcomp function was used for principal component analysis (PCA). Gene Ontology 625 
(GO) analysis was performed using DAVID (Huang da et al., 2009b).  626 
 627 
Statistical Analyses 628 
No power calculations were performed to predetermine sample sizes. Statistical 629 
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analyses were performed using GraphPad Prism software. Images of cells or embryos are 630 
representative of at least three independent experiments. Statistical methods used to 631 
analyse high throughput sequencing data and proteomics data are described in the 632 
respective sections of the Methods.  633 
 634 
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 897 
Figure 1. Biochemical characterisation of epitope-tagged MTA proteins 898 
A. Schematic of MTA proteins with different protein domains indicated as coloured 899 
boxes, and the C-terminal epitope tags indicated. The model below shows the MTA- 900 
and HDAC-containing subunit joined to the CHD4-containing subunit through the 901 
MBD protein. 902 
B. Tagged MTA proteins in heterozygously targeted cell lines were immunoprecipitated 903 
and subsequent western blots probed with antibodies indicated at right. Solid black 904 
triangles indicate the locations of untagged proteins and open triangles show the 905 
position of epitope-tagged proteins in the anti-Mta1, Mta2 or Mta3 panels; and a 906 
grey triangle shows the location of IgG bands in the anti-Mbd3 panel. 10% of the 907 
input was loaded into “Input” lanes. Molecular weights in kDa are shown at left. (Full 908 
western blot images are available in Mendeley Data.) 909 
C. Proteins co-purifying with Mta1, Mta2 or Mta3 in IP-mass spectrometry experiments 910 
in wild type cells (top) or Mbd3-null cells (bottom). Proteins showing significant 911 
enrichment with the bait protein are located outside the dotted lines. For all panels 912 
the protein being immunoprecipitated is indicated in red, the other MTA proteins in 913 
purple, and other NuRD components in blue. Each IP/Mass spec experiment set 914 
comprised three independent immunoprecipitations from one nuclear extract 915 
preparation. 916 
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D. Relative enrichment of indicated proteins in MTA pulldowns from wild type (WT) or 917 
Mbd3-null (Mbd3KO) ES cells, normalised to 2x MTA proteins. NuRD components 918 
comprising the remodelling subunit are labelled in blue, those comprising the 919 
deacetylase subunit in red. As MTA proteins are the bait in these experiments, they 920 
may be isolated more efficiently than their interaction partners. Error bars represent 921 
standard deviation from three (Mta1 and Mta2) or six (Mta3) replicate pulldowns. 922 
 923 
Figure. 2. Mta proteins show similar chromatin binding patterns 924 
A. ChIP-seq peaks identified for Mta1 and Mta2 (left), Mta1 and Mta3 (middle) or 925 
Mta2 and Mta3 (right) are plotted by enrichment for each protein. Peaks called for 926 
both proteins are indicated in the overlap.  927 
B. Overlap of peaks identified by ChIP-seq for each MTA protein in wild type ES cells. 928 
Total peak numbers are indicated below each protein name. Each ChIP-seq dataset 929 
was made from biological triplicates.  930 
C. Comparison of Mta1 and Mta2 peaks with Chd4 peaks, as in Panel (B). 931 
D. ChIP-seq enrichment for indicated proteins or histone modifications is plotted 932 
across different subsets of Mta-bound sites. Mta1/2/3 refers to peaks identified in 933 
all three ChIP-seq datasets, whereas “Mta1 Only”, “Mta2 Only” or “Mta3 Only” 934 
refer to peaks only called for that protein.  935 
E. Average enrichment of density plots in (D) are plotted for different subsets of Mta 936 
ChIP-seq peaks.  937 
 938 
Figure 3. Mta1/Mta2/Mta3 triple null ES cells represent a complete NuRD KO 939 
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A. Western blots of wild type (Control), double or triple-null ES cell nuclear extract was 940 
probed with antibodies indicated at right. LaminB1 acts as a loading control. 941 
Approximate sizes are indicated in kDa. 942 
B. Phase-contrast images of wild type or Mta123∆ ES cells in 2i+LIF conditions. Scale 943 
bars represent 100µm.  944 
C. Western blots of anti-Chd4 immunoprecipitation of nuclear extract from indicated 945 
cell lines (top) probed with antibodies indicated at right. For the Gatad2b and Mbd3 946 
blots, arrowheads indicate target proteins, while an asterisk marks a non-specific IgG 947 
bands. 10% of the input was loaded into “Input” lanes. Approximate sizes are 948 
indicated in kDa. 949 
D. Western blot of a time course of Mta3 deletion in Mta1∆Mta2∆Mta3Flox/Flox: Cre-ER 950 
(Mta12∆3F/F) or Control (Mta12∆3F/F without Cre-ER) ES cells probed for indicated 951 
NuRD component proteins or RNA Polymerase II as a loading control (RNAPII). The 952 
time course is indicated at the top as Days + tamoxifen.  953 
E. Western blot showing rescue of Mta123∆ ES cells by ectopic expression of Mta1, 954 
Mta2 or Mta3 from a transgene (TG). Total RNA Polymerase II acts as a loading 955 
control (RNAPII). For all western blots molecular weight is indicated at left in kDa. 956 
F. Model of NuRD complex structure. Upon loss of Mbd3 most of the NuRD complex 957 
falls apart into the Chd4-containing remodeller subcomplex and the MTA-containing 958 
deacetylase subcomplex, but some intact Mbd2-NuRD still remains. Upon loss of all 959 
three MTA proteins no intact NuRD remains, both Mbd3 and Gatad2a/b become 960 
unstable and neither of the intact subcomplexes remain. 961 
 962 
Figure 4. Mta proteins act redundantly to control gene expression 963 
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A. Comparison of gene expression in Mta123∆ ES cells and wild type (WT) ES cells. Each 964 
circle represents a gene: red indicates spike-in controls, blue indicates genes that are 965 
not differentially expressed to a significant degree, and green indicates differentially 966 
expressed genes (2404 increased, 1293 decreased) defined with an adjusted p-value 967 
< 0.05 and a log2 fold-change > 1. N=3 for each genotype. 968 
B. Fold change in gene expression is plotted for different subsets of genes. All genes are 969 
plotted in black, while subsets of genes located nearest to ChIP-seq peaks for the 970 
indicated proteins +Chd4 and which show significant changes in expression 971 
compared to wild type cells are plotted in dashed coloured lines as indicated. The 972 
number of genes in each of the Mta categories are: all genes (32271), all 973 
differentially expressed (n=3701), Mta1+2+3 (n=1738), Mta1+2 (n=1460), Mta1 974 
(n=1020) and Mta2 (n=924). 975 
C. Principal component analysis of RNAseq data from ES cell lines of indicated 976 
genotypes in either self-renewing conditions (2i) or after 48 hours in the absence of 977 
two inhibitors and LIF (Diff48). Each point represents a biological replicate. 978 
D. GO term enrichment for genes differentially expressed in Mta123∆ ES cells (left) or 979 
Mbd3∆ ES cells (right) compared to wild type cells in 2iL conditions. For each 980 
comparison the top five most significant gene ontology terms are plotted by log10 of 981 
the Benjamini-adjusted p-value. The significant GO terms and p-values were 982 
calculated using David v.6.8 983 
E. Genes associated with indicated GO terms plotted by fold change in expression in 984 
Mta123∆ ES cells (x-axis) or Mbd3∆ ES cells (y-axis). Genes are coloured if they are 985 
differentially expressed (log2 fold-change > 1 and adjusted p-value < 0.05) in either 986 
comparison as indicated. The dotted lines show the fold-change cut-off of 2. GO-987 
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terms were identified using David v.6.8 (Huang da et al., 2009a) using a Benjamini 988 
score with a cutoff of 0.05. 989 
F. Genes associated with core NuRD peaks, with an MTA-only peak, with a Chd4 peak 990 
and an MTA-peak but not an Mbd3 peak (Chd4+Mta-Mbd3 genes), or with an MTA-991 
peak but not a Chd4 peak (MTA-only genes) were divided into quartiles based upon 992 
expression levels in wild type cells. Change in gene expression is plotted on the x-axis 993 
and calculated significance of the expression change on the y-axis. Those genes 994 
significantly misexpressed (|log2FC|>1; p≤0.05) are indicated in red, genes showing 995 
no significant change are plotted in black. The percentage of genes within each 996 
quartile which is significantly misexpressed is indicated at the top of each plot. 997 
 998 
Figure 5. NuRD activity maintains an appropriate ES cell differentiation trajectory 999 
A. Phase contrast pictures of ES cells of indicated genotypes after 5 days in 1000 
neuroectoderm differentiation conditions (N2B27). White arrowheads in the Mbd3∆ 1001 
panel indicate pockets of ES-like cells. Scale bars represent 100 µm.  1002 
B. Expression of indicated genes in the neuroectoderm differentiation time course was 1003 
measured by RT-qPCR in Control (green) Mta123∆ (magenta) or Mbd3∆ (blue) ES 1004 
cells. N ≥ 3 biological replicates, error bars indicate SEM. 1005 
C. Phase contrast images of embryoid body outgrowths of indicated genotypes after 12 1006 
days in differentiation conditions (N2B27 + 10% serum). Scale bars represent 100µm. 1007 
D. Expression of indicated genes in embryoid body cultures over time was measured by 1008 
RT-qPCR as in Panel (B).  1009 
E. Comparison of expression data for wild type, Mbd3∆ or Mta123∆ ES cells in self-1010 
renewing (2i) conditions or after 48 hours in differentiation conditions (48h N2B27) 1011 
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with mouse embryonic single cell RNA-seq data from (Mohammed et al., 2017). 1012 
Larger shading encloses biological replicates, smaller circles represent individual 1013 
cells. PC4 vs PC1 is plotted in Fig. EV5F and a loading plot in EV5G. 1014 
 1015 
Figure 6. NuRD-null ES cells cannot contribute to normal embryonic development 1016 
A. Composite images of representative chimaeric embryos made with control 1017 
(Mta1Flox/∆Mta2+/+Mta3Flox/Flox) or Mta123∆ ES cells. ES-derived cells express the 1018 
Kusabira Orange fluorescent marker. Sox2 indicates epiblast cells and Cdx2 is 1019 
expressed in trophectoderm cells. Arrows indicate examples of K-Orange expressing 1020 
cells in the mutant embryos. Scale bars = 20µm. 1021 
B. (Top) Number of K-Orange expressing cells observed in chimaeric embryos obtained 1022 
using control ES cells, Mta123∆ ES cells, or Mta123∆ ES cells in which Mta2 was 1023 
reintroduced on a constitutively expressed transgene (Mta123∆+Mta2TG). P-values 1024 
calculated using a two-tailed t-test. (Middle) Mean number of K-Orange cells per 1025 
embryo separated by Sox2 expression. P-values calculated using a two-tailed t-test. 1026 
(Bottom) Number of K-Orange and Caspase-3 positive cells per embryo. P-values 1027 
calculated using a one-tailed t-test: *P < 0.05, ****P < 0.0001, “ns” = not significant. 1028 
C. Model of NuRD function during differentiation of pluripotent cells. NuRD facilitates 1029 
lineage commitment of ES cells after exit from pluripotency (red arrows), allowing 1030 
cells to form differentiated cell types (Top). In the absence of Mbd3, residual NuRD 1031 
activity ensures cells retain the appropriate differentiation trajectory, but the cells 1032 
are unable to reach a differentiated cell fate (dotted red arrows; Middle). In the 1033 
absence of all three MTA proteins there is no residual NuRD activity and ES cells are 1034 
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unable to either achieve appropriate lineage commitment, or to maintain the proper 1035 
differentiation trajectory (dotted arrows, Bottom).  1036 
 1037 
Expanded View Figures 1038 
 1039 
Figure EV1. Expression of MTA genes during early mouse development 1040 
RNAseq data from (Boroviak et al., 2014) plotted at indicated days of mouse 1041 
development for each of the MTA genes. All data points are shown, with horizontal 1042 
bars indicating the mean. 1043 
 1044 
Figure EV2. Chromatin features of MTA-bound peaks 1045 
A. Comparison of ChIP-seq peaks for Mta3 and Chd4. The number of Mta3-only, Chd4-1046 
only, or Mta3+Chd4 peaks are indicated. 1047 
B. Features of peaks containing two of the three MTA proteins, as in Figure 2D.  1048 
C. Distribution of ChIP-seq peaks identified as shared amongst all three MTA proteins 1049 
(MTA123) or as unique for indicated MTA proteins is plotted relative to Refseq 1050 
transcription start sites (TSS) on the x-axis. Note distance is on a log10 scale. 1051 
D. Average enrichment of indicated features is shown for peaks for each Mta protein 1052 
which do or do not also contain Chd4. The number of peaks in each set is indicated 1053 
as n. 1054 
E. Average enrichment of DNA methylation across MTA peaks with or without Chd4, as 1055 
in Panel (D).  1056 
F. Significance of GO-term enrichment for genes associated with peaks for different 1057 
combinations of Mta proteins with or without Chd4.  1058 
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 1059 
Figure EV3. MTA reporter and knockout alleles 1060 
A. Schematic of the Mta1 “Knockout First” reporter allele Mta1tm1a(EUCOMM)Wtsi (Top). 1061 
Exons are depicted as boxes, with normal coding exons as filled boxes. Exons around 1062 
the insertion site are numbered. Coding exons not able to be translated in the 1063 
depicted allele are shaded in light blue. The targeting resulted in an FRT-flanked 1064 
LacZ-Neo fusion protein being expressed from the endogenous Mta1 promoter and 1065 
preventing transcription of most Mta1 exons. Recombination between FRT sites is 1066 
achieved by expression of FLP recombinase (Middle), removing the LacZ-Neo 1067 
cassette and restoration of Mta1 coding potential. Subsequent recombination 1068 
between LoxP sites by Cre recombinase (Bottom) results in loss of Exon 2 and 1069 
subsequent exons are out of frame.  1070 
B. Schematic of the Mta2tm1a(EUCOMM)Wtsi allele as in panel (A). In this allele the neo gene 1071 
is expressed from a human ß-actin promoter and expression of Cre results in excision 1072 
of exons 4-13.  1073 
C. Schematic of the Mta3tm3a(KOMP)Wtsi allele as in panel (A). 1074 
D. Western blot of nuclear extracts made from each single mutant probed with 1075 
indicated antibodies. Anti-Rbp1 NTD (RNA polymerase II) acts as a loading control.  1076 
E. Phase-contrast images of cell lines of indicated genotype in self-renewing conditions. 1077 
Scale bars indicate 100 µm.  1078 
F. Comparison of gene expression in indicated MTA single mutant ES cells and wild type 1079 
(WT) ES cells. Each circle represents a gene: red indicates genes that are not 1080 
differentially expressed to a significant degree, and green indicates differentially 1081 
expressed genes. The number of up- and down-regulated genes defined with an 1082 
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adjusted p-value < 0.05 and a log2 fold-change > 1 is indicated in each plot. N=3 for 1083 
each genotype. 1084 
G. Overlap of misexpressed genes in indicated single mutant ES cells. The number of 1085 
genes in each overlap category are indicated. 1086 
H.  Gene expression data for each single MTA mutant ES line, the Mbd3∆ ES line and 1087 
the Mta123∆ ES line and their control parental lines (WT) in self-renewing (2i) 1088 
conditions are plotted relative to that of mouse embryonic single cell RNA-seq data 1089 
from (Mohammed et al., 2017) (smaller grey circles). 1090 
 1091 
Figure EV4. Control of gene expression by the MTA proteins 1092 
A. Western blot of nuclear extract from cell lines indicated at the bottom in 2iL 1093 
conditions probed with antibodies listed at right. Arrows indicate the locations of the 1094 
two Mbd2 isoforms in the anti-Mbd2 panel, and of the three Mbd3 isoforms in the 1095 
anti-Mbd3 panel. The grey triangle indicates the location of Mbd3-3xFLAG, which was 1096 
present in the Mbd2∆ line used. Anti-Rbp1 NTD (RNA polymerase II) acts as a loading 1097 
control. Approximate sizes are indicated at left in kDa. 1098 
B. Western blot of indicated proteins in wild type and Mbd3∆ ES cells in 2iL conditions. 1099 
Anti-Rbp1 NTD (RNA polymerase II subunit) acts as a loading control.  1100 
C. Comparison of gene expression changes in wild type (Mta123WT = control ES cell line 1101 
derived at the same time as the parent of the Mta123∆ ES cell line), Mbd3∆ and 1102 
Mta123∆ ES cells in self-renewing (2iL) conditions. The top 100 genes contributing to 1103 
PC2 from Figure 5E are shown. 1104 
D. Common ChIP-seq peaks for Chd4 and all three MTA proteins (Core NuRD peaks) 1105 
were assigned to the nearest genes. These genes were then divided into four equal 1106 
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groups based upon expression levels in wild type cells, and their expression in Mbd3∆ 1107 
ES cells (top panels) or Mta123∆ ES cells (bottom panels) is plotted relative to that in 1108 
wild type ES cells. Change in gene expression is plotted on the x-axis and calculated 1109 
significance of the expression change on the y-axis. Those genes significantly 1110 
misexpressed (|log2FC|>1; p≤0.05) are indicated in red, genes showing no significant 1111 
change are plotted in black. The percentage of misexpressed genes located within 1112 
each quartile is indicated above each graph. 1113 
 1114 
Figure EV5. Failure of differentiation in Mta123∆ ES cells 1115 
A. Phase contrast images of ES cells of indicated genotypes induced to differentiate for 5 1116 
days in N2B27.  Scale bars represent 100 µm. 1117 
B. Comparison of gene expression in indicated ES cell lines in undifferentiated 1118 
conditions or after 5 days in neuroectoderm differentiation conditions (N2B27). RT-1119 
qPCR was carried out in triplicate at each time point for a minimum of three 1120 
biological replicates. Error bars indicate SEM. 1121 
C. GO term enrichment for genes differentially expressed in Mbd3∆ ES cells (left) or 1122 
Mta123∆ ES cells (right) after 48h of differentiation in N2B27. For each comparison 1123 
the top five most significant gene ontology terms are plotted by log10 of the 1124 
Benjamini-adjusted p-value. Significant GO terms and p-values were calculated using 1125 
David v.6.8 (Huang da et al., 2009a). 1126 
D. Expression of genes associated with indicated GO terms is plotted by fold change in 1127 
expression in Mta123∆ ES cells (x-axis) or Mbd3∆ ES cells (y-axis) after 48h of 1128 
differentiation in N2B27. Genes are coloured if they are differentially expressed (log2 1129 
fold-change > 1 and padj value < 0.05) in either comparison as indicated. The dotted 1130 
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lines show the fold-change cut-off of 2. GO-terms were identified using David v.6.8 1131 
using a Benjamini score with a cutoff of 0.05. 1132 
E. Comparison of gene expression in indicated ES cell lines induced to differentiate 1133 
towards mesoderm. qPCR was carried out in triplicate at each time point for a 1134 
minimum of three biological replicates. Error bars indicate SEM. 1135 
F. Same as Figure 5E, plotting PC4 vs PC1.  1136 
G. Loading plot for Figure 5E. A selection of key genes is highlighted in different colours 1137 
based upon a published classification of early embryonic gene expression (Boroviak et 1138 
al., 2014). 1139 
H. Composite images of representative chimaeric embryos as in Figure 6A stained with 1140 
an anti-activated Caspase 3 antibody. Arrows indicate an example of an orange, 1141 
apoptotic cell. Scale bars = 20µm. 1142 
 1143 
 1144 
Table EV1. ES cell lines and mice 1145 
Table EV2. Antibodies  1146 
Table EV3. Sequencing Datasets 1147 
Appendix Figure 1. High correlation amongst replicates of ChIP-seq data 1148 
Appendix Figure 2. Mta3 stop codon selection in ES cells 1149 
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2iLKO v 2iLWT, expr group: 3 , sig genes =  8 / 82






























































































































































































































































































































































































































































































































































































































































2iLKO v 2iLWT, expr group: 3 , sig genes =  720 / 3278

































2iLKO v 2iLWT, expr group: 3 , sig genes =  5 / 30




























































































































































































































































































































































































































































































































































































































































































































































































































2iLKO v 2iLWT, expr group: 2 , sig genes =  1265 / 3263





















































































2iLKO v 2iLWT, expr group: 2 , sig genes =  40 / 90










































































































































































































































































































































































































































































































































































































































































































































































2iLKO v 2iLWT, expr group: 2 , sig genes =  814 / 2085


















































2iLKO v 2iLWT, expr group: 2 , sig genes =  17 / 42


























































































































































































































































































































































2iLKO v 2iLWT, expr group: 4 , sig genes =  387 / 5241







































































2iLKO v 2iLWT, expr group: 4 , sig genes =  3 / 80







































































































































































































































































































2iLKO v 2iLWT, expr group: 4 , sig genes =  288 / 3779









































2iLKO v 2iLWT, expr group: 4 , sig genes =  0 / 28
































































































































































































































































































































































































































2iLKO v 2iLWT, expr group: 1 , sig genes =  267 / 1797



























































































2iLKO v 2iLWT, expr group: 1 , sig genes =  18 / 97





























































2iLKO v 2iLWT, expr group: 1 , sig genes =  9 / 51

























































































































































































































































































































































2iLKO v 2iLWT, expr group: 1 , sig genes =  174 / 1138
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